Authors:
Aroutcheva, AA
Simoes, JA
Behbakht, K
Faro, S
Citation: Aa. Aroutcheva et al., Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems, CLIN INF D, 33(7), 2001, pp. 1022-1027
Authors:
Simoes, JA
Hashemi, FB
Aroutcheva, AA
Heimler, I
Spear, GT
Shott, S
Faro, S
Citation: Ja. Simoes et al., Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: Relationship to biotypes and other pathogenic characteristics, J INFEC DIS, 184(1), 2001, pp. 22-27
Authors:
Simoes, JA
Aroutcheva, A
Heimler, I
Shott, S
Faro, S
Citation: Ja. Simoes et al., Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility, AM J OBST G, 185(5), 2001, pp. 1186-1190
Authors:
Hashemi, FB
Ghassemi, M
Faro, S
Aroutcheva, A
Spear, GT
Citation: Fb. Hashemi et al., Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis, J INFEC DIS, 181(5), 2000, pp. 1574-1580
Authors:
Koenigsberg, RA
Gul, N
Faro, S
Elfont, R
Baker, K
Tsai, F
Citation: Ra. Koenigsberg et al., Hyperacute cerebral enhancement: The earliest predictor of hemorrhage by MR imaging?, J NEUROIMAG, 9(4), 1999, pp. 235-236
Authors:
Gordon, J
Mohamed, F
Vinitski, S
Knobler, RL
Curtis, M
Faro, S
Khalili, K
Citation: J. Gordon et al., Utilization of experimental animal model for correlative multispectral MRIand pathological analysis of brain tumors, MAGN RES IM, 17(10), 1999, pp. 1495-1502
Citation: Ja. Weigelt et S. Faro, Antimicrobial therapy for surgical prophylaxis and for intra-abdominal andgynecologic infections, AM J SURG, 176(6), 1998, pp. 1S-3S